NCT02410603View on ClinicalTrials.gov

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions

Lung CancerLung NeoplasmsCancer of LungCancer of the LungNeoplasms, LungNeoplasms, PulmonaryPulmonary CancerPulmonary NeoplasmsCarcinoma, Non-small-cell LungAdenocarcinomaSquamous Cell Carcinoma

Trial Locations (1)

55905

Mayo Clinic, Rochester